StockData
Strata Critical Medical, Inc. logo

Strata Critical Medical, Inc. (SRTA) stock

SRTANasdaqTransportation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 17/3055% below fair value
$4.96−0.28 (-5.34%)

Close on Nov 18, 2026Market cap $438.80MP/E 9.7Yield –

Strata Critical Medical free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Strata Critical Medical's free cash flow for the twelve months ending Jun 30, 2026 was -$48.45M. For fiscal 2025 it was -$58.51M. The highest annual figure on record is -$10.91M in fiscal 2019.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$58.51M–
FY2024Dec 31, 2024-$33.38M–
FY2023Dec 31, 2023-$34.46M–
FY2021Sep 30, 2021-$15.91M–
FY2020Sep 30, 2020-$11.20M–
FY2019Sep 30, 2019-$10.91M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$3.20M–
Q1 FY2026CQ1 2026Mar 31, 2026-$1.29M–
Q4 FY2025CQ4 2025Dec 31, 2025-$10.16M–
Q3 FY2025CQ3 2025Sep 30, 2025-$40.20M–
Q2 FY2025CQ2 2025Jun 30, 2025-$5.30M–
Q1 FY2025CQ1 2025Mar 31, 2025-$2.86M–
Q4 FY2024CQ4 2024Dec 31, 2024-$6.33M–
Q3 FY2024CQ3 2024Sep 30, 2024-$2.95M-322.3%
Q2 FY2024CQ2 2024Jun 30, 2024-$7.73M–
Q1 FY2024CQ1 2024Mar 31, 2024-$16.37M–
Q4 FY2023CQ4 2023Dec 31, 2023-$9.34M–
Q3 FY2023CQ3 2023Sep 30, 2023$1.33M–
Q2 FY2023CQ2 2023Jun 30, 2023-$8.94M–
Q1 FY2023CQ1 2023Mar 31, 2023-$17.50M–
Q4 FY2021CQ3 2021Sep 30, 2021-$5.86M–

More Strata Critical Medical figures

See a number that looks wrong?